KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment

NCT00750776 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 212

Last updated 2013-04-16

No results posted yet for this study

Summary

Rating and registration in KMS database of all patients in anti-psychotic treatment with 8 selected items from PANSS, GAF, 21 selected items from UKU, 3 selected items from TSQM. and measurement of compliance. Frequency of use of rating scales per participating health care professional.

Conditions

  • Antipsychotic Treatment
  • Quality Assurance
  • Medical Treatment

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY
  • Psychiatric Centre Rigshospitalet

    lead OTHER

Principal Investigators

  • Soren Blikenberg · Research Centre for Psychiatry Vordingborg

  • Michael Maagensen · Children Psychiatry Holbaek

  • Karin Byrsting · Odense University Hospital Odense C Psychiatric Hospital Slagelse

  • Marianne Jacoby · Outpatient TreatmentCopenhagen K

  • Peter Christoffersen · Psychiatric Hospital Slagelse

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2012-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00750776 on ClinicalTrials.gov